Peripheral gating of pain signals by endogenous lipid mediators.
about
A lipid gate for the peripheral control of painNeonatal inflammatory pain and systemic inflammatory responses as possible environmental factors in the development of autism spectrum disorder of juvenile rats.Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic painDual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain ManagementStructure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acidsParabens inhibit fatty acid amide hydrolase: A potential role in paraben-enhanced 3T3-L1 adipocyte differentiationPeripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptiveAmino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in RatsPro-resolving lipid mediators are leads for resolution physiology.Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms.Large-scale interaction effects reveal missing heritability in schizophrenia, bipolar disorder and posttraumatic stress disorder.Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis techniqueAlterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control studyChemical probes to potently and selectively inhibit endocannabinoid cellular reuptake.Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol/high fat diet induced pancreatitisChemical structure and morphology of dorsal root ganglion neurons from naive and inflamed mice.Endocannabinoids and acute pain after total knee arthroplasty.Pain-enhancing mechanism through interaction between TRPV1 and anoctamin 1 in sensory neurons.Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-αFatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms.Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndromeA Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.A Molecular Signature of Myalgia in Myotonic Dystrophy 2Endogenous N-acyl taurines regulate skin wound healing.High levels of endogenous lipid mediators (N-acylethanolamines) in women with chronic widespread pain during acute tissue trauma.Association of morphine-induced analgesic tolerance with changes in gene expression of GluN1 and MOR1 in rat spinal cord and midbrain.Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells.New insights of nociceptor sensitization in bone cancer pain.N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1.Tyrosine Residue in the TRPV1 Vanilloid Binding Pocket Regulates Deactivation Kinetics.A simple method for simultaneous determination of N-arachidonoylethanolamine, N-oleoylethanolamine, N-palmitoylethanolamine and 2-arachidonoylglycerol in human cells.Cannabis and Pain: A Clinical ReviewTRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling.Role of Polyunsaturated Fatty Acids and Their Metabolites on Stem Cell Proliferation and Differentiation.TFOS DEWS II pain and sensation report.Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment.Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
P2860
Q26995053-BC1F5C07-800C-4429-95B9-911888A54EB1Q27303121-6C1CD58B-A865-4A9F-9EAF-F71E9C016479Q27311231-A4E52215-2084-4DD2-B9E6-E4420F26A801Q28067493-D806794C-BFC5-4ADA-B256-64A2817388BCQ28257042-2E8FD3E1-072C-45EF-9CE4-61930BC7FFDAQ28393331-4E914F6E-42D2-4C73-BBD7-D303D7386EA8Q28396233-106DD51D-CE96-4B93-8CF0-941D35089319Q28548007-BDA225BD-C79C-49C2-92A4-A177ED42AEB8Q30829097-24E9C3C7-95E6-4D28-ACE8-780F75D52B99Q33610506-8A51CFCA-1B94-46F9-A1EA-89C331F73CABQ33635688-51AABBBC-DA81-4ECB-8A05-5B11B477E544Q33774088-2AC345E5-6B75-47F5-B10D-DB3B81502C31Q33791893-966CC975-04D9-46CB-9FF7-081CD4A987BBQ34557589-B20EB0C5-8CF7-426C-AA30-CAE5979ED040Q34565750-EA9B2332-658B-4C8A-828A-EC56B2BED267Q34634289-C0AE870E-99C9-485D-843A-D883F215E4D5Q34988278-F09E24DA-93D6-4F97-92B7-23246BEFA160Q35549332-2518C68C-3247-4791-A08F-B1115690245BQ35660108-C13FFB2F-B081-43A4-9708-9A57551125B9Q35987617-E47898CF-3450-47B6-AF52-7000AC9E95D9Q35999420-682F20ED-4058-44AD-A301-DE8CDC242259Q36001928-F66B6E06-7C7E-4AE3-B883-E4392B95EE08Q36395889-7BCFDC46-9639-4BD4-B4E4-456C14B1E9D9Q36823364-11ECB284-5010-4EE0-8A7B-F81F77CB36EDQ37008336-F22962C4-2B14-4667-8D66-C383799BA8EEQ37142854-D78CA481-6D3A-415A-815B-46028D0231C7Q37229877-5F8B47D5-CAC3-4B51-B849-E46F1A974039Q37366435-AF9DC620-A497-40BA-BDA1-5E36C4B432FBQ37716341-C9B8F09D-3FA9-4F33-A222-6623B4BE8444Q38303224-76B0BB3B-580B-47BB-B1B6-71B4E565135FQ38521270-5C489F32-79F4-4346-8DDF-AF4D0747F105Q38682038-6A6D7171-EC8E-4607-89C4-23A54610AC83Q38773336-27D75D5A-D5E8-405B-B494-F99CE1DC0045Q38927583-A2ED11E8-AB41-490A-B527-D6C9B4371FF7Q39150465-7723053F-0D78-466B-971B-CFE8E6CD02BFQ39260828-4442D1BA-A0B8-4846-AD2A-A695E34FD3FDQ39368607-6D2BC254-9069-4AD4-8EAB-80752C005DFAQ39453338-B57E3B90-4356-4CD8-BE23-B156CB2478FDQ40758763-44D0114A-7C94-4792-AE9C-A04640E603BBQ41001072-123B7E72-870E-4F1D-9746-9478AF613BE0
P2860
Peripheral gating of pain signals by endogenous lipid mediators.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Peripheral gating of pain signals by endogenous lipid mediators.
@ast
Peripheral gating of pain signals by endogenous lipid mediators.
@en
type
label
Peripheral gating of pain signals by endogenous lipid mediators.
@ast
Peripheral gating of pain signals by endogenous lipid mediators.
@en
prefLabel
Peripheral gating of pain signals by endogenous lipid mediators.
@ast
Peripheral gating of pain signals by endogenous lipid mediators.
@en
P2860
P356
P1433
P1476
Peripheral gating of pain signals by endogenous lipid mediators.
@en
P2093
Daniele Piomelli
Oscar Sasso
P2860
P2888
P304
P356
10.1038/NN.3612
P407
P577
2014-01-28T00:00:00Z